FMBA completes first phase of preclinical trials of COVID-19 vaccine

This was reported on the website stopkoronavirus.rf.

“Completed the first stage of preclinical screening studies (specific immunogenicity, activation of humoral and T-cell immunity, primary safety), as well as a study on the characterization of recombinant antigens in relation to binding to natural receptors and virus neutralizing activity of antibodies induced by these antigens, created prototype vaccines based on recombinant proteins, ”the message says.

Earlier, the head of the FMBA, Veronika Skvortsova, said what needs to be done so that Russia avoids the third wave of coronavirus infection COVID-19.

Doctor-immunologist, Candidate of Medical Sciences Nikolai Kryuchkov, in an interview with FAN, commented on the situation with the pandemic.